WEAVER CONSULTING GROUP Brainstorm Cell Therapeutics Inc. Transaction History

WEAVER CONSULTING GROUP portfolio value:

$20,000
portfolio value

Brainstorm Cell Therapeutics Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -10.21% -10.68K shares 126K $4.42 93.97K
Q3 2022 call Increase 0.00% 70K shares 20K $4.42 70K
Q2 2022 share Decrease -19.50% -25.34K shares -148K $2.76 104.65K
Q1 2022 share Decrease -16.40% -25.5K shares -185K $3.36 130K
Q4 2021 share Increase +201.94% 104K shares 452K $4.23 155.5K
Q3 2021 share Increase +5.36% 2.61K shares -16K $3.3 51.5K
Q2 2021 share Decrease -2.24% -1.11K shares -6K $3.8 48.88K
Q1 2021 share Increase 0.00% 50K shares 192K $3.83 50K